Rapid Dose Therapeutics Corp. (CSE:DOSE)
Canada
· Delayed Price · Currency is CAD 0.1800
0.00 (0.00%)
Aug 15, 2025, 2:05 PM EDT
Rapid Dose Therapeutics Revenue
Rapid Dose Therapeutics had revenue of 782.74K CAD in the quarter ending May 31, 2025, with 96.18% growth. This brings the company's revenue in the last twelve months to 2.47M, up 109.47% year-over-year. In the fiscal year ending February 28, 2025, Rapid Dose Therapeutics had annual revenue of 2.09M with 104.34% growth.
Revenue (ttm)
2.47M
Revenue Growth
+109.47%
P/S Ratio
9.69
Revenue / Employee
n/a
Employees
n/a
Market Cap
23.92M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.75B |
| Green Thumb Industries | 1.57B |
| Trulieve Cannabis | 1.62B |
| Sienna Senior Living | 929.68M |
| dentalcorp Holdings | 1.62B |
| Cronos Group | 177.69M |
| WELL Health Technologies | 990.34M |
| Extendicare | 1.51B |